| scholarly article | Q13442814 |
| P2093 | author name string | Bettina C Fries | |
| Immaculata Xess | |||
| Neena Jain | |||
| Xiabo Wang | |||
| Fahmi Hasan | |||
| P2860 | cites work | International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia | Q30453797 |
| Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance | Q30701532 | ||
| Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces | Q30799502 | ||
| Quantitative variation of biofilms among strains in natural populations of Candida albicans | Q30892906 | ||
| Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: an analysis of microbiological data | Q31152900 | ||
| Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003. | Q33753405 | ||
| Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America | Q33894467 | ||
| Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms | Q33982871 | ||
| Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources | Q34453558 | ||
| Biofilm formation by and antifungal susceptibility of Candida isolates from urine | Q35690002 | ||
| Biofilm formation by Candida species on the surface of catheter materials in vitro | Q35775012 | ||
| Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia | Q35913891 | ||
| Candida albicans biofilms: more than filamentation | Q36167141 | ||
| Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis | Q36467675 | ||
| Antifungal combinations against Candida albicans biofilms in vitro | Q36879905 | ||
| Microevolution of Candida albicans strains during catheter-related candidemia | Q37511316 | ||
| Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. | Q39558196 | ||
| In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. | Q39657947 | ||
| Molecular epidemiology of clinical Cryptococcus neoformans strains from India | Q39803868 | ||
| Attributable mortality of nosocomial candidemia, revisited | Q44386169 | ||
| Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars | Q45016433 | ||
| DNA- and PCR-fingerprinting in fungi. | Q50698683 | ||
| Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. | Q51745109 | ||
| Deletion of the NOT4 gene impairs hyphal development and pathogenicity in Candida albicans. | Q52552842 | ||
| Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. | Q52676310 | ||
| Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS | Q71575447 | ||
| Effect of serum concentration on Candida biofilm formation on acrylic surfaces | Q74041792 | ||
| Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care | Q78623274 | ||
| Risk factors for Candida non-albicans candidemia | Q80876690 | ||
| P433 | issue | 8-9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biofilm | Q467410 |
| P304 | page(s) | 753-761 | |
| P577 | publication date | 2009-05-04 | |
| P1433 | published in | Microbes and Infection | Q15760242 |
| P1476 | title | Biofilm formation in clinical Candida isolates and its association with virulence | |
| P478 | volume | 11 |
| Q41020292 | 1-n-Hexadecyl-3-methylimidazolium methanesulfonate and chloride salts with effective activities against Candida tropicalis biofilms. |
| Q64972797 | A Predominance of Clade 17 Candida albicans Isolated From Hemocultures in a Tertiary Care Hospital in Thailand. |
| Q35945338 | A murine model for catheter-associated candiduria |
| Q59812614 | A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections |
| Q35170466 | Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. |
| Q58576582 | Antifungal Susceptibility and Biofilm Production of spp. Isolated from Clinical Samples |
| Q90000039 | Antifungal activity of curcumin-silver nanoparticles against fluconazole-resistant clinical isolates of Candida species |
| Q39244568 | Antifungal activity of phenolic compounds identified in flowers from North Eastern Portugal against Candida species |
| Q46269923 | Antifungal susceptibility and phenotypic virulence markers of Candida species isolated from Nepal |
| Q33993054 | Antifungal susceptibility patterns, in vitro production of virulence factors, and evaluation of diagnostic modalities for the speciation of pathogenic Candida from blood stream infections and vulvovaginal candidiasis. |
| Q38264633 | Biofilm formation by clinical isolates and its relevance to clinical infections |
| Q36285233 | Biofilm production by Candida: comparison of bloodstream isolates with cervical isolates |
| Q45357693 | Biofilm production in oral Candida isolates from HIV-positive individuals from Pune, India |
| Q35201457 | Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity |
| Q38787461 | CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity. |
| Q26778729 | Candida albicans Biofilms and Human Disease |
| Q42923451 | Candida albicans Fungaemia following Traumatic Urethral Catheterisation in a Paraplegic Patient with Diabetes Mellitus and Candiduria Treated by Caspofungin |
| Q44516466 | Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections |
| Q48163274 | Candida glabrata Biofilms: How Far Have We Come? |
| Q38163927 | Candida glabrata: a review of its features and resistance |
| Q33825621 | Candida infections of the genitourinary tract |
| Q39993914 | Candida species isolated from urban bats of Londrina-Paraná, Brazil and their potential virulence |
| Q38019018 | Candida species: new insights into biofilm formation. |
| Q36901716 | Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates |
| Q36139925 | Clinical implications of microbial biofilms in chronic rhinosinusitis and orbital cellulitis |
| Q28539436 | Coriandrum sativum L. (Coriander) essential oil: antifungal activity and mode of action on Candida spp., and molecular targets affected in human whole-genome expression |
| Q37738190 | Current status of ureteral stent technologies: comfort and antimicrobial resistance |
| Q34327784 | Determination of the effect of Nd:YAG laser irradiation through dentinal tubules on several oral pathogens |
| Q64966596 | Divergent Approaches to Virulence in C. albicans and C. glabrata: Two Sides of the Same Coin. |
| Q35048626 | Effect of tetrandrine against Candida albicans biofilms |
| Q59058005 | Epidemiology and Virulence Determinants including Biofilm Profile of Candida Infections in an ICU in a Tertiary Hospital in India |
| Q39413837 | Experimental biofilm-related Candida infections |
| Q49679927 | Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All. |
| Q42738793 | In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species |
| Q53641731 | In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm. |
| Q41564148 | In vitro antifungal activity and in vivo antibiofilm activity of cerium nitrate against Candida species |
| Q43094518 | In vitro biofilm activity of non-Candida albicans Candida species. |
| Q33455239 | Inactivation of Candida biofilms by non-thermal plasma and its enhancement for fungistatic effect of antifungal drugs |
| Q36208305 | Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11. |
| Q37950850 | Insights into Candida tropicalis nosocomial infections and virulence factors. |
| Q45039401 | Long-term oropharyngeal colonization by C. albicans in children with cystic fibrosis |
| Q38109647 | Methods for obtaining reliable and reproducible results in studies of Candida biofilms formed in vitro |
| Q39173771 | Micafungin is more active against Candida albicans biofilms with high metabolic activity |
| Q35574796 | Microbial colonization of irradiated pathogenic yeast to catheter surfaces: Relationship between adherence, cell surface hydrophobicity, biofilm formation and antifungal susceptibility. A scanning electron microscope analysis |
| Q64239859 | Microevolution of the pathogenic yeasts and during antifungal therapy and host infection |
| Q35175626 | Mucosal biofilms of Candida albicans |
| Q42277119 | Mutation of the CgPDR16 gene attenuates azole tolerance and biofilm production in pathogenic Candida glabrata |
| Q92811631 | On Commensalism of Candida |
| Q34067285 | Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates |
| Q83642000 | Oxidative stress response and virulence factors in Candida glabrata clinical isolates |
| Q49490643 | Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans |
| Q34079974 | Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm |
| Q42515150 | Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection |
| Q90706918 | Quantitative analysis of the expression of fluconazole-resistant genes in strains of Candida albicans isolated from elderly people at their admission in an intensive care unit in Manizales, Colombia |
| Q26861656 | Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms |
| Q36250461 | Repeated applications of photodynamic therapy on Candida glabrata biofilms formed in acrylic resin polymerized. |
| Q90442682 | Resensitization of Fluconazole-Resistant Urinary Candida spp. Isolates by Amikacin through Downregulation of Efflux Pump Genes |
| Q34221581 | Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital |
| Q37734438 | Sexual biofilm formation in Candida tropicalis opaque cells |
| Q90224483 | Silver Nanoparticles Addition in Poly(Methyl Methacrylate) Dental Matrix: Topographic and Antimycotic Studies |
| Q34578357 | Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates. |
| Q37026730 | Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates |
| Q34058071 | Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation. |
| Q40920367 | Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production |
| Q41989116 | Temporal Profile of Biofilm Formation, Gene Expression and Virulence Analysis in Candida albicans Strains |
| Q39022559 | The Activities of Adhesion and Biofilm Formation by Candida tropicalis Clinical Isolates Display Significant Correlation with Its Multilocus Sequence Typing |
| Q38954405 | The Correlation Between Biofilm Production and Catheter-Related Bloodstream Infections Sustained by Candida. A Case Control Study. |
| Q58093225 | The MNN2 Gene Knockout Modulates the Antifungal Resistance of Biofilms of Candida glabrata |
| Q36260914 | The Membrane Proteins Involved in Virulence of Cronobacter sakazakii Virulent G362 and Attenuated L3101 Isolates |
| Q41989973 | The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data |
| Q38955918 | Zap1 control of cell-cell signaling in Candida albicans biofilms |
Search more.